Arellano, Vicenta D.

HRN: 23-18-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2023
CEFUROXIME 1.5GM (VIAL)
06/09/2023
06/09/2023
IV
1.5 Grams
Now
S/P LTCS
Waiting Final Action 
06/09/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/09/2023
06/09/2023
IV
500 Mg
Now
S/P LTCS
Waiting Final Action 
06/09/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/09/2023
06/16/2023
IV
500 Mg
Every 8 Hours
S/P LTCS
Waiting Final Action 
06/09/2023
CEFUROXIME 1.5GM (VIAL)
06/09/2023
06/16/2023
IV
1.5 Grams
Every 8 Hours
S/P LTCS
Waiting Final Action 
06/10/2023
CEFUROXIME 500MG (TAB)
06/10/2023
06/17/2023
PO
500mg
BID X 7 Days
S/P Primary Ltcs; Thickly Msaf
Waiting Final Action 
06/10/2023
METRONIDAZOLE 500MG (TAB)
06/10/2023
06/17/2023
PO
500mg
TID X 7 Days
S/P Primary Ltcs; Thickly Msaf
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: